Furthermore, a heightened ratio of luteinizing hormone to follicle-stimulating hormone (LH/FSH) in patients with PCOS results in hormonal dysregulation and atypical aromatase expression, subsequently elevating androgen concentrations and enhancing AMH secretion from granulosa cells (GCs) (20). This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.